Interpace Biosciences (IDXG) Reports Q4 EPS of $0.82

Interpace Biosciences (OTC: IDXG) reported Q4 EPS of $0.82.Revenue for the quarter came in at $9.22 million.

For earnings history and earnings-related data on Interpace Biosciences (IDXG) click here.

You May Also Be Interested In

• JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
• JPMorgan Starts Nippon Life India Asset Management Ltd (NAM:IN) at Overweight
• Edgewell stock surges on report of rejected takeover bid